NBIX vs SOTK · P/E 45, rev $1.77B vs P/E 46, rev $20.9M
Neurocrine Biosciences Inc (NBIX) versus Sono-Tek Corp (SOTK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Sono-Tek Corp (SOTK) is a scientific & technical instruments company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SOTK revenue for 2026-02-28 was $20.9M. Net income was $1.8M. SOTK currently screens at market cap $57.4M and trailing P/E 45.6.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SOTK currently screens at market cap $57.4M and trailing P/E 45.6.
Not investment advice. Open the NBIX and SOTK stock pages for the full models.
Not investment advice.